Cargando…

Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies

BACKGROUND: Currently, revisions to the ICH S1 guidance on rodent carcinogenicity testing are being proposed. Application of this approach would reduce the use of animals in accordance with the 3Rs principles (reduce/refine/replace). The method would also shift resources to focus on more scientific...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Shuichi, Shigano, Miyuki, Wako, Yumi, Kawasako, Kazufumi, Satomoto, Kensuke, Mitsumoto, Tatsuya, Fukuda, Takayuki, Ohyama, Wakako, Morita, Takeshi, Hayashi, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725540/
https://www.ncbi.nlm.nih.gov/pubmed/34983681
http://dx.doi.org/10.1186/s41021-021-00222-1
_version_ 1784626140204236800
author Hamada, Shuichi
Shigano, Miyuki
Wako, Yumi
Kawasako, Kazufumi
Satomoto, Kensuke
Mitsumoto, Tatsuya
Fukuda, Takayuki
Ohyama, Wakako
Morita, Takeshi
Hayashi, Makoto
author_facet Hamada, Shuichi
Shigano, Miyuki
Wako, Yumi
Kawasako, Kazufumi
Satomoto, Kensuke
Mitsumoto, Tatsuya
Fukuda, Takayuki
Ohyama, Wakako
Morita, Takeshi
Hayashi, Makoto
author_sort Hamada, Shuichi
collection PubMed
description BACKGROUND: Currently, revisions to the ICH S1 guidance on rodent carcinogenicity testing are being proposed. Application of this approach would reduce the use of animals in accordance with the 3Rs principles (reduce/refine/replace). The method would also shift resources to focus on more scientific mechanism-based carcinogenicity assessments and promote safe and ethical development of new small molecule pharmaceuticals. In the revised draft, findings such as cellular hypertrophy, diffuse and/or focal cellular hyperplasia, persistent tissue injury and/or chronic inflammation, preneoplastic changes, and tumors are listed as histopathology findings of particular interest for identifying carcinogenic potential. In order to predict hepatocarcinogenicity of test chemicals based on the results from 2- or 4-week repeated dose studies, we retrospectively reanalyzed the results of a previous collaborative study on the liver micronucleus assay. We focused on liver micronucleus induction in combination with histopathological changes including hypertrophy, proliferation of oval cells or bile duct epithelial cells, tissue injuries, regenerative changes, and inflammatory changes as the early responses of hepatocarcinogenesis. For these early responses, A total of 20 carcinogens, including 14 genotoxic hepatocarcinogens (Group A) and 6 non-liver-targeted genotoxic carcinogens (Group B) were evaluated. RESULTS: In the Group A chemicals, 5 chemicals (NPYR, MDA, NDPA, 2,6-DNT, and NMOR) showed all of the 6 early responses in hepatocarcinogenesis. Five chemicals (DMN, 2,4-DNT, QUN, 2-AAF, and TAA) showed 4 responses, and 4 chemicals (DAB, 2-NP, MCT, and Sudan I) showed 3 responses. All chemicals exhibited at least 3 early responses. Contrarily, in the Group B chemicals (6 chemicals), 3 of the 6 early responses were observed in 1 chemical (MNNG). No more than two responses were observed in 3 chemicals (MMC, MMS, and KA), and no responses were observed in 2 chemicals (CP and KBrO3). CONCLUSION: Evaluation of liver micronucleus induction in combination with histopathological examination is useful for detecting hepatocarcinogens. This assay takes much less time than routine long-term carcinogenicity studies.
format Online
Article
Text
id pubmed-8725540
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87255402022-01-06 Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies Hamada, Shuichi Shigano, Miyuki Wako, Yumi Kawasako, Kazufumi Satomoto, Kensuke Mitsumoto, Tatsuya Fukuda, Takayuki Ohyama, Wakako Morita, Takeshi Hayashi, Makoto Genes Environ Research BACKGROUND: Currently, revisions to the ICH S1 guidance on rodent carcinogenicity testing are being proposed. Application of this approach would reduce the use of animals in accordance with the 3Rs principles (reduce/refine/replace). The method would also shift resources to focus on more scientific mechanism-based carcinogenicity assessments and promote safe and ethical development of new small molecule pharmaceuticals. In the revised draft, findings such as cellular hypertrophy, diffuse and/or focal cellular hyperplasia, persistent tissue injury and/or chronic inflammation, preneoplastic changes, and tumors are listed as histopathology findings of particular interest for identifying carcinogenic potential. In order to predict hepatocarcinogenicity of test chemicals based on the results from 2- or 4-week repeated dose studies, we retrospectively reanalyzed the results of a previous collaborative study on the liver micronucleus assay. We focused on liver micronucleus induction in combination with histopathological changes including hypertrophy, proliferation of oval cells or bile duct epithelial cells, tissue injuries, regenerative changes, and inflammatory changes as the early responses of hepatocarcinogenesis. For these early responses, A total of 20 carcinogens, including 14 genotoxic hepatocarcinogens (Group A) and 6 non-liver-targeted genotoxic carcinogens (Group B) were evaluated. RESULTS: In the Group A chemicals, 5 chemicals (NPYR, MDA, NDPA, 2,6-DNT, and NMOR) showed all of the 6 early responses in hepatocarcinogenesis. Five chemicals (DMN, 2,4-DNT, QUN, 2-AAF, and TAA) showed 4 responses, and 4 chemicals (DAB, 2-NP, MCT, and Sudan I) showed 3 responses. All chemicals exhibited at least 3 early responses. Contrarily, in the Group B chemicals (6 chemicals), 3 of the 6 early responses were observed in 1 chemical (MNNG). No more than two responses were observed in 3 chemicals (MMC, MMS, and KA), and no responses were observed in 2 chemicals (CP and KBrO3). CONCLUSION: Evaluation of liver micronucleus induction in combination with histopathological examination is useful for detecting hepatocarcinogens. This assay takes much less time than routine long-term carcinogenicity studies. BioMed Central 2022-01-04 /pmc/articles/PMC8725540/ /pubmed/34983681 http://dx.doi.org/10.1186/s41021-021-00222-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hamada, Shuichi
Shigano, Miyuki
Wako, Yumi
Kawasako, Kazufumi
Satomoto, Kensuke
Mitsumoto, Tatsuya
Fukuda, Takayuki
Ohyama, Wakako
Morita, Takeshi
Hayashi, Makoto
Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
title Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
title_full Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
title_fullStr Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
title_full_unstemmed Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
title_short Detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
title_sort detection of hepatocarcinogens by combination of liver micronucleus assay and histopathological examination in 2-week or 4-week repeated dose studies
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725540/
https://www.ncbi.nlm.nih.gov/pubmed/34983681
http://dx.doi.org/10.1186/s41021-021-00222-1
work_keys_str_mv AT hamadashuichi detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT shiganomiyuki detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT wakoyumi detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT kawasakokazufumi detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT satomotokensuke detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT mitsumototatsuya detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT fukudatakayuki detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT ohyamawakako detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT moritatakeshi detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies
AT hayashimakoto detectionofhepatocarcinogensbycombinationoflivermicronucleusassayandhistopathologicalexaminationin2weekor4weekrepeateddosestudies